Pharma R&D & Clinical Services · Indirect
Monitoring · monthly
Procurement Category Intelligence

Drug Delivery System Development

PDF
Overview
Market size
2.15T
global, USD
CAGR
6.3%
base to forecast
Buyer power
-2.3
supplier-favoured
Suppliers
8
tracked players
Signals
12
1 high severity

Risk Exceptions

3
United States - Switzerland105United States21China2Germany1Switzerland1Brazil1South Africa1France1United Kingdom
8 countries · 1 lane from 33 sourced statements

Buyer Power Score

-50+5
Negotiating position for this category, scored from supplier-favoured to buyer-favoured
-2.3 ⓘ
Equal to a supplier-favoured market into 2026 cover

Recommended stance. Pre-qualify dual CDMO, lock capacity early

Catalysts & Deadlines

3
12 SignalsLive in the feed
12 ActionsRecommended
1 HighSeverity

Supplier Intelligence

8See all

Industry News

3

Related categories

Contract Research Organizations - PreclinicalContract Research Organizations - ClinicalClinical Trial Site ManagementClinical Data Management ServicesClinical Trial Patient RecruitmentPharmacovigilance ServicesDrug Safety MonitoringRegulatory Affairs Consulting